Published in PLoS One on May 21, 2013
CellNet: network biology applied to stem cell engineering. Cell (2014) 4.10
Stoichiometry of Gata4, Mef2c, and Tbx5 influences the efficiency and quality of induced cardiac myocyte reprogramming. Circ Res (2014) 1.80
Induced regeneration--the progress and promise of direct reprogramming for heart repair. Nat Med (2013) 1.17
Induction of diverse cardiac cell types by reprogramming fibroblasts with cardiac transcription factors. Development (2014) 1.10
Chemical Enhancement of In Vitro and In Vivo Direct Cardiac Reprogramming. Circulation (2016) 0.93
Fibroblast Growth Factors and Vascular Endothelial Growth Factor Promote Cardiac Reprogramming under Defined Conditions. Stem Cell Reports (2015) 0.90
In vivo cardiac reprogramming using an optimal single polycistronic construct. Cardiovasc Res (2015) 0.85
Enhanced efficiency of genetic programming toward cardiomyocyte creation through topographical cues. Biomaterials (2015) 0.82
Improved Generation of Induced Cardiomyocytes Using a Polycistronic Construct Expressing Optimal Ratio of Gata4, Mef2c and Tbx5. J Vis Exp (2015) 0.81
Eribulin mesylate exerts specific gene expression changes in pericytes and shortens pericyte-driven capillary network in vitro. Vasc Cell (2014) 0.81
Fetal heart extract facilitates the differentiation of human umbilical cord blood-derived mesenchymal stem cells into heart muscle precursor cells. Cytotechnology (2014) 0.80
Cardiac fibrosis in myocardial infarction-from repair and remodeling to regeneration. Cell Tissue Res (2016) 0.79
Cardiac reprogramming: from mouse toward man. Curr Opin Genet Dev (2013) 0.79
Transdifferentiation of human endothelial progenitors into smooth muscle cells. Biomaterials (2016) 0.79
Re-patterning of H3K27me3, H3K4me3 and DNA methylation during fibroblast conversion into induced cardiomyocytes. Stem Cell Res (2016) 0.79
Recent advances in direct cardiac reprogramming. Curr Opin Genet Dev (2015) 0.78
Direct Reprogramming-The Future of Cardiac Regeneration? Int J Mol Sci (2015) 0.78
'Above all, do no harm': safeguarding pluripotent stem cell therapy against iatrogenic tumorigenesis. Stem Cell Res Ther (2014) 0.78
In situ reprogramming to transdifferentiate fibroblasts into cardiomyocytes using adenoviral vectors: Implications for clinical myocardial regeneration. J Thorac Cardiovasc Surg (2016) 0.77
Forward Programming of Cardiac Stem Cells by Homogeneous Transduction with MYOCD plus TBX5. PLoS One (2015) 0.77
Small RNAs make big impact in cardiac repair. Circ Res (2015) 0.77
Reprogramming cell fate: a changing story. Front Cell Dev Biol (2014) 0.77
Concise review: reprogramming strategies for cardiovascular regenerative medicine: from induced pluripotent stem cells to direct reprogramming. Stem Cells Transl Med (2014) 0.77
Cardiac Niche Influences the Direct Reprogramming of Canine Fibroblasts into Cardiomyocyte-Like Cells. Stem Cells Int (2015) 0.77
Targeting Mll1 H3K4 methyltransferase activity to guide cardiac lineage specific reprogramming of fibroblasts. Cell Discov (2016) 0.76
Direct Cardiac Reprogramming: Advances in Cardiac Regeneration. Biomed Res Int (2015) 0.76
Notch Inhibition Enhances Cardiac Reprogramming by Increasing MEF2C Transcriptional Activity. Stem Cell Reports (2017) 0.76
GATA4 transgenic mice as an in vivo model of congenital heart disease. Int J Mol Med (2015) 0.76
Direct Cardiac Cellular Reprogramming for Cardiac Regeneration. Curr Treat Options Cardiovasc Med (2016) 0.75
Core Transcription Factors, MicroRNAs, and Small Molecules Drive Transdifferentiation of Human Fibroblasts Towards The Cardiac Cell Lineage. Sci Rep (2017) 0.75
Integrated analysis of gene expression and DNA methylation changes induced by hepatocyte growth factor in human hepatocytes. Mol Med Rep (2015) 0.75
Reprogramming for cardiac regeneration. Glob Cardiol Sci Pract (2014) 0.75
Reduced dosage of β-catenin provides significant rescue of cardiac outflow tract anomalies in a Tbx1 conditional null mouse model of 22q11.2 deletion syndrome. PLoS Genet (2017) 0.75
Improving cardiac reprogramming for heart regeneration. Curr Opin Organ Transplant (2016) 0.75
Corticothalamic Projection Neuron Development beyond Subtype Specification: Fog2 and Intersectional Controls Regulate Intraclass Neuronal Diversity. Neuron (2016) 0.75
The roles of Mesp family proteins: functional diversity and redundancy in differentiation of pluripotent stem cells and mammalian mesodermal development. Protein Cell (2015) 0.75
Generation of an inducible fibroblast cell line for studying direct cardiac reprogramming. Genesis (2016) 0.75
Single cell qPCR reveals that additional HAND2 and microRNA-1 facilitate the early reprogramming progress of seven-factor-induced human myocytes. PLoS One (2017) 0.75
Global transcriptomic analysis of induced cardiomyocytes predicts novel regulators for direct cardiac reprogramming. J Cell Commun Signal (2017) 0.75
Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell (2006) 120.51
Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell (2007) 101.42
Fiji: an open-source platform for biological-image analysis. Nat Methods (2012) 56.92
Germline transmission and tissue-specific expression of transgenes delivered by lentiviral vectors. Science (2002) 17.71
Direct reprogramming of fibroblasts into functional cardiomyocytes by defined factors. Cell (2010) 15.58
Imaging neural activity in worms, flies and mice with improved GCaMP calcium indicators. Nat Methods (2009) 13.39
Induction of pluripotent stem cells from primary human fibroblasts with only Oct4 and Sox2. Nat Biotechnol (2008) 10.29
Direct cell reprogramming is a stochastic process amenable to acceleration. Nature (2009) 8.71
Activation of cardiac gene expression by myocardin, a transcriptional cofactor for serum response factor. Cell (2001) 8.09
In vivo reprogramming of murine cardiac fibroblasts into induced cardiomyocytes. Nature (2012) 7.80
Gene regulatory networks in the evolution and development of the heart. Science (2006) 7.67
Functional cardiomyocytes derived from human induced pluripotent stem cells. Circ Res (2009) 7.09
Heart repair by reprogramming non-myocytes with cardiac transcription factors. Nature (2012) 6.65
Human embryonic stem cells can differentiate into myocytes with structural and functional properties of cardiomyocytes. J Clin Invest (2001) 6.59
Multipotent flk-1+ cardiovascular progenitor cells give rise to the cardiomyocyte, endothelial, and vascular smooth muscle lineages. Dev Cell (2006) 6.19
A high-efficiency system for the generation and study of human induced pluripotent stem cells. Cell Stem Cell (2008) 5.99
Heart regeneration. Nature (2011) 5.91
A drug-inducible system for direct reprogramming of human somatic cells to pluripotency. Cell Stem Cell (2008) 5.83
Direct conversion of human fibroblasts to multilineage blood progenitors. Nature (2010) 5.35
Imaging cellular signals in the heart in vivo: Cardiac expression of the high-signal Ca2+ indicator GCaMP2. Proc Natl Acad Sci U S A (2006) 4.71
Conversion of mouse fibroblasts into cardiomyocytes using a direct reprogramming strategy. Nat Cell Biol (2011) 4.64
Reprogramming of murine and human somatic cells using a single polycistronic vector. Proc Natl Acad Sci U S A (2008) 4.48
Myocardin is a master regulator of smooth muscle gene expression. Proc Natl Acad Sci U S A (2003) 4.35
Survey of studies examining mammalian cardiomyocyte DNA synthesis. Circ Res (1998) 3.87
The cardiac homeobox gene Csx/Nkx2.5 lies genetically upstream of multiple genes essential for heart development. Development (1999) 3.74
Directed transdifferentiation of mouse mesoderm to heart tissue by defined factors. Nature (2009) 3.70
Production of de novo cardiomyocytes: human pluripotent stem cell differentiation and direct reprogramming. Cell Stem Cell (2012) 3.66
MicroRNA-mediated in vitro and in vivo direct reprogramming of cardiac fibroblasts to cardiomyocytes. Circ Res (2012) 3.53
Reprogramming factor stoichiometry influences the epigenetic state and biological properties of induced pluripotent stem cells. Cell Stem Cell (2011) 3.31
Generation of functional murine cardiac myocytes from induced pluripotent stem cells. Circulation (2008) 3.11
Mesp1 acts as a master regulator of multipotent cardiovascular progenitor specification. Cell Stem Cell (2008) 3.07
Restricted inactivation of serum response factor to the cardiovascular system. Proc Natl Acad Sci U S A (2004) 2.98
Forced alignment of mesenchymal stem cells undergoing cardiomyogenic differentiation affects functional integration with cardiomyocyte cultures. Circ Res (2008) 2.80
Inefficient reprogramming of fibroblasts into cardiomyocytes using Gata4, Mef2c, and Tbx5. Circ Res (2012) 2.74
A new approach to transcription factor screening for reprogramming of fibroblasts to cardiomyocyte-like cells. J Mol Cell Cardiol (2012) 2.71
Lentiviral vectors and protocols for creation of stable hESC lines for fluorescent tracking and drug resistance selection of cardiomyocytes. PLoS One (2009) 2.62
The Hand1 and Hand2 transcription factors regulate expansion of the embryonic cardiac ventricles in a gene dosage-dependent manner. Development (2004) 2.61
Modulation of cardiac growth and development by HOP, an unusual homeodomain protein. Cell (2002) 2.53
Hop is an unusual homeobox gene that modulates cardiac development. Cell (2002) 2.52
Embryonic stem cells differentiate in vitro into cardiomyocytes representing sinusnodal, atrial and ventricular cell types. Mech Dev (1993) 2.48
Mesp1 coordinately regulates cardiovascular fate restriction and epithelial-mesenchymal transition in differentiating ESCs. Cell Stem Cell (2008) 2.46
Regeneration gaps: observations on stem cells and cardiac repair. J Am Coll Cardiol (2006) 2.13
Myocardin-related transcription factor-a controls myofibroblast activation and fibrosis in response to myocardial infarction. Circ Res (2010) 2.00
Differences in gap junction channels between cardiac myocytes, fibroblasts, and heterologous pairs. Am J Physiol (1992) 1.95
K+ currents regulate the resting membrane potential, proliferation, and contractile responses in ventricular fibroblasts and myofibroblasts. Am J Physiol Heart Circ Physiol (2005) 1.89
Mouse ES cell-derived cardiac precursor cells are multipotent and facilitate identification of novel cardiac genes. J Clin Invest (2008) 1.80
Myocardin induces cardiomyocyte hypertrophy. Circ Res (2006) 1.74
Electrophysiological properties of human mesenchymal stem cells. J Physiol (2003) 1.53
Serum response factor orchestrates nascent sarcomerogenesis and silences the biomineralization gene program in the heart. Proc Natl Acad Sci U S A (2008) 1.39
Myocardin is sufficient and necessary for cardiac gene expression in Xenopus. Development (2005) 1.37
Myocardin is required for cardiomyocyte survival and maintenance of heart function. Proc Natl Acad Sci U S A (2009) 1.33
Transgenic analysis of the thyroid-responsive elements in the alpha-cardiac myosin heavy chain gene promoter. J Biol Chem (1993) 1.29
Efficient conversion of astrocytes to functional midbrain dopaminergic neurons using a single polycistronic vector. PLoS One (2011) 1.21
Rational optimization of reprogramming culture conditions for the generation of induced pluripotent stem cells with ultra-high efficiency and fast kinetics. Cell Res (2011) 1.19
Lentiviral vectors bearing the cardiac promoter of the Na+-Ca2+ exchanger report cardiogenic differentiation in stem cells. Mol Ther (2008) 1.13
Conduction slowing by the gap junctional uncoupler carbenoxolone. Cardiovasc Res (2003) 1.11
Electrotonic loading of anisotropic cardiac monolayers by unexcitable cells depends on connexin type and expression level. Am J Physiol Cell Physiol (2009) 1.09
Contribution of a non-inactivating potassium current to the resting membrane potential of fusion-competent human myoblasts. J Physiol (1996) 1.05
Transmembrane electrical characteristics of cultured human skeletal muscle cells. J Cell Physiol (1987) 0.97
Electrophysiological properties of cardiomyocytes isolated from CYP2J2 transgenic mice. Mol Pharmacol (2007) 0.90
Electrophysiological characterization of murine HL-5 atrial cardiomyocytes. Am J Physiol Cell Physiol (2006) 0.78
RNA-guided gene activation by CRISPR-Cas9-based transcription factors. Nat Methods (2013) 4.85
Nanopattern-induced changes in morphology and motility of smooth muscle cells. Biomaterials (2005) 2.94
Synthetic nanostructures inducing differentiation of human mesenchymal stem cells into neuronal lineage. Exp Cell Res (2007) 2.46
Multifunctional nanorods for gene delivery. Nat Mater (2003) 2.09
Tissue-engineered cardiac patch for advanced functional maturation of human ESC-derived cardiomyocytes. Biomaterials (2013) 1.97
Nanotopography-induced changes in focal adhesions, cytoskeletal organization, and mechanical properties of human mesenchymal stem cells. Biomaterials (2009) 1.97
Consensus statement on chronic and subacute high altitude diseases. High Alt Med Biol (2005) 1.96
Development of universal antidotes to control aptamer activity. Nat Med (2009) 1.93
Long intergenic noncoding RNA HOTAIR is overexpressed and regulates PTEN methylation in laryngeal squamous cell carcinoma. Am J Pathol (2012) 1.91
Sustained release of proteins from electrospun biodegradable fibers. Biomacromolecules (2005) 1.86
Genetic variations in Tibetan populations and high-altitude adaptation at the Himalayas. Mol Biol Evol (2010) 1.77
Quantitative comparison of intracellular unpacking kinetics of polyplexes by a model constructed from quantum dot-FRET. Mol Ther (2008) 1.76
The effect of the alignment of electrospun fibrous scaffolds on Schwann cell maturation. Biomaterials (2007) 1.72
The role of extracellular matrix composition in structure and function of bioengineered skeletal muscle. Biomaterials (2011) 1.68
Natural polymers for gene delivery and tissue engineering. Adv Drug Deliv Rev (2006) 1.66
Simultaneous delivery of siRNA and paclitaxel via a "two-in-one" micelleplex promotes synergistic tumor suppression. ACS Nano (2011) 1.65
Evaluating the intracellular stability and unpacking of DNA nanocomplexes by quantum dots-FRET. J Control Release (2006) 1.64
Polyethylenimine-grafted multiwalled carbon nanotubes for secure noncovalent immobilization and efficient delivery of DNA. Angew Chem Int Ed Engl (2005) 1.61
Mesoscopic hydrogel molding to control the 3D geometry of bioartificial muscle tissues. Nat Protoc (2009) 1.45
Aligned Protein-Polymer Composite Fibers Enhance Nerve Regeneration: A Potential Tissue-Engineering Platform. Adv Funct Mater (2007) 1.43
Significance of synthetic nanostructures in dictating cellular response. Nanomedicine (2005) 1.42
Mast cell-derived particles deliver peripheral signals to remote lymph nodes. J Exp Med (2009) 1.42
Controlled release of heparin from poly(epsilon-caprolactone) electrospun fibers. Biomaterials (2005) 1.42
Surface-aminated electrospun nanofibers enhance adhesion and expansion of human umbilical cord blood hematopoietic stem/progenitor cells. Biomaterials (2006) 1.41
Cardiac fibroblast paracrine factors alter impulse conduction and ion channel expression of neonatal rat cardiomyocytes. Cardiovasc Res (2009) 1.40
Chitosan nanoparticles for oral drug and gene delivery. Int J Nanomedicine (2006) 1.38
Fibroblast growth factor homologous factor 13 regulates Na+ channels and conduction velocity in murine hearts. Circ Res (2011) 1.37
Characterization of topographical effects on macrophage behavior in a foreign body response model. Biomaterials (2010) 1.33
Cartilage tissue engineering using differentiated and purified induced pluripotent stem cells. Proc Natl Acad Sci U S A (2012) 1.31
Diverse functions of cationic Mn(III) N-substituted pyridylporphyrins, recognized as SOD mimics. Free Radic Biol Med (2011) 1.31
Novel micropatterned cardiac cell cultures with realistic ventricular microstructure. Biophys J (2009) 1.30
Pluripotent stem cell-derived cardiac tissue patch with advanced structure and function. Biomaterials (2011) 1.30
SOD therapeutics: latest insights into their structure-activity relationships and impact on the cellular redox-based signaling pathways. Antioxid Redox Signal (2013) 1.29
Structural coupling of cardiomyocytes and noncardiomyocytes: quantitative comparisons using a novel micropatterned cell pair assay. Am J Physiol Heart Circ Physiol (2008) 1.28
Engineered skeletal muscle tissue networks with controllable architecture. Biomaterials (2008) 1.28
In vivo wound healing of diabetic ulcers using electrospun nanofibers immobilized with human epidermal growth factor (EGF). Biomaterials (2007) 1.28
Self-assembled supramolecular hydrogels formed by biodegradable PEO-PHB-PEO triblock copolymers and alpha-cyclodextrin for controlled drug delivery. Biomaterials (2006) 1.26
The effect of the degree of chitosan deacetylation on the efficiency of gene transfection. Biomaterials (2004) 1.25
Biomaterials approach to expand and direct differentiation of stem cells. Mol Ther (2007) 1.24
Phase II randomized trial of autologous formalin-fixed tumor vaccine for postsurgical recurrence of hepatocellular carcinoma. Clin Cancer Res (2004) 1.23
Electrohydrodynamics: A facile technique to fabricate drug delivery systems. Adv Drug Deliv Rev (2009) 1.23
Genetic evidence of paleolithic colonization and neolithic expansion of modern humans on the tibetan plateau. Mol Biol Evol (2013) 1.22
Balancing protection and release of DNA: tools to address a bottleneck of non-viral gene delivery. J R Soc Interface (2009) 1.22
Functional reentry in cultured monolayers of neonatal rat cardiac cells. Am J Physiol Heart Circ Physiol (2003) 1.22
Myogenic Induction of Aligned Mesenchymal Stem Cell Sheets by Culture on Thermally Responsive Electrospun Nanofibers. Adv Mater (2007) 1.20
Nonviral direct conversion of primary mouse embryonic fibroblasts to neuronal cells. Mol Ther Nucleic Acids (2012) 1.20
Preparation and characterization of polypseudorotaxanes based on block-selected inclusion complexation between poly(propylene oxide)-poly(ethylene oxide)-poly(propylene oxide) triblock copolymers and alpha-cyclodextrin. J Am Chem Soc (2003) 1.20
Peripheral nerve regeneration by microbraided poly(L-lactide-co-glycolide) biodegradable polymer fibers. J Biomed Mater Res A (2004) 1.19
Temperature-responsive hydroxybutyl chitosan for the culture of mesenchymal stem cells and intervertebral disk cells. Biomaterials (2005) 1.19
MR imaging of biodegradable polymeric microparticles: a potential method of monitoring local drug delivery. Magn Reson Med (2005) 1.19
Nanotopography as modulator of human mesenchymal stem cell function. Biomaterials (2012) 1.16
Chitosan-DNA nanoparticles delivered by intrabiliary infusion enhance liver-targeted gene delivery. Int J Nanomedicine (2006) 1.16
PEI-g-chitosan, a novel gene delivery system with transfection efficiency comparable to polyethylenimine in vitro and after liver administration in vivo. Bioconjug Chem (2006) 1.15
Identification of a Tibetan-specific mutation in the hypoxic gene EGLN1 and its contribution to high-altitude adaptation. Mol Biol Evol (2013) 1.14
Advanced materials and processing for drug delivery: the past and the future. Adv Drug Deliv Rev (2012) 1.14
Galactosylated ternary DNA/polyphosphoramidate nanoparticles mediate high gene transfection efficiency in hepatocytes. J Control Release (2005) 1.13
Synthetic mast-cell granules as adjuvants to promote and polarize immunity in lymph nodes. Nat Mater (2012) 1.12
Inducing hepatic differentiation of human mesenchymal stem cells in pellet culture. Biomaterials (2006) 1.11
Microfluidic synthesis of multifunctional Janus particles for biomedical applications. Lab Chip (2012) 1.10
Engineering biosynthetic excitable tissues from unexcitable cells for electrophysiological and cell therapy studies. Nat Commun (2011) 1.10
Expansion of engrafting human hematopoietic stem/progenitor cells in three-dimensional scaffolds with surface-immobilized fibronectin. J Biomed Mater Res A (2006) 1.10
Biomimetic engineered muscle with capacity for vascular integration and functional maturation in vivo. Proc Natl Acad Sci U S A (2014) 1.10
Electrotonic loading of anisotropic cardiac monolayers by unexcitable cells depends on connexin type and expression level. Am J Physiol Cell Physiol (2009) 1.09
Viscoelastic behaviour of human mesenchymal stem cells. BMC Cell Biol (2008) 1.09
Interaction of human mesenchymal stem cells with disc cells: changes in extracellular matrix biosynthesis. Spine (Phila Pa 1976) (2006) 1.09
Label-free, high-throughput measurements of dynamic changes in cell nuclei using angle-resolved low coherence interferometry. Biophys J (2008) 1.09
Whole-cell-analysis of live cardiomyocytes using wide-field interferometric phase microscopy. Biomed Opt Express (2010) 1.08
Electrical pacing counteracts intrinsic shortening of action potential duration of neonatal rat ventricular cells in culture. J Mol Cell Cardiol (2006) 1.08
Dual-sensitive micellar nanoparticles regulate DNA unpacking and enhance gene-delivery efficiency. Adv Mater (2010) 1.07
Functional cardiac tissue engineering. Regen Med (2012) 1.07
Stable immobilization of rat hepatocyte spheroids on galactosylated nanofiber scaffold. Biomaterials (2005) 1.07
Rapid formation of multicellular spheroids in double-emulsion droplets with controllable microenvironment. Sci Rep (2013) 1.07
Engineering strategies to enhance nanoparticle-mediated oral delivery. J Biomater Sci Polym Ed (2008) 1.06
Nucleic acid scavengers inhibit thrombosis without increasing bleeding. Proc Natl Acad Sci U S A (2012) 1.05
Injectable drug-delivery systems based on supramolecular hydrogels formed by poly(ethylene oxide)s and alpha-cyclodextrin. J Biomed Mater Res A (2003) 1.05
Effect of Electromechanical Stimulation on the Maturation of Myotubes on Aligned Electrospun Fibers. Cell Mol Bioeng (2008) 1.04
Peripheral nerve regeneration with sustained release of poly(phosphoester) microencapsulated nerve growth factor within nerve guide conduits. Biomaterials (2003) 1.04
Intranasal gene transfer by chitosan-DNA nanospheres protects BALB/c mice against acute respiratory syncytial virus infection. Hum Gene Ther (2002) 1.04
Quantum dot-based theranostics. Nanoscale (2009) 1.03
Local tissue geometry determines contractile force generation of engineered muscle networks. Tissue Eng Part A (2012) 1.03
Controlled release from fibers of polyelectrolyte complexes. J Control Release (2005) 1.02
Transfection efficiency and transgene expression kinetics of mRNA delivered in naked and nanoparticle format. J Control Release (2013) 1.02
Guidance of stem cell fate on 2D patterned surfaces. Biomaterials (2012) 1.02
Emerging links between surface nanotechnology and endocytosis: impact on nonviral gene delivery. Nano Today (2010) 1.02
New polyphosphoramidate with a spermidine side chain as a gene carrier. J Control Release (2002) 1.01
Cytotoxic effects of Mn(III) N-alkylpyridylporphyrins in the presence of cellular reductant, ascorbate. Free Radic Res (2011) 1.01
Polyphosphoesters in drug and gene delivery. Adv Drug Deliv Rev (2003) 1.01
Three-dimensional co-culture of rat hepatocyte spheroids and NIH/3T3 fibroblasts enhances hepatocyte functional maintenance. Acta Biomater (2005) 1.01
Cardiac cell therapy in vitro: reproducible assays for comparing the efficacy of different donor cells. IEEE Eng Med Biol Mag (2008) 1.01
Co-culture of umbilical cord blood CD34+ cells with human mesenchymal stem cells. Tissue Eng (2006) 1.01
Implantation of mouse embryonic stem cell-derived cardiac progenitor cells preserves function of infarcted murine hearts. PLoS One (2010) 1.01
Tuning physical properties of nanocomplexes through microfluidics-assisted confinement. Nano Lett (2011) 1.00
Induced pluripotent stem cell-derived cardiac progenitors differentiate to cardiomyocytes and form biosynthetic tissues. PLoS One (2013) 1.00